Narrative review of changing medical and feminist perspectives on menopause: From femininity and ageing to risk and choice

Psychology, Health and Medicine

Volumn 10, Issue 3, 2005, Pages 276-290

  Murtagh, Madeleine J ^a   Hepworth, Julie ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Choice; Decision making; Femininity; Hormone replacement therapy; Menopause; Risk; Subjectivity

Indexed keywords

HORMONE;

AGING; DECISION MAKING; FEMALE; FEMININITY; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; NOMENCLATURE; PRIORITY JOURNAL; REVIEW; RISK;

EID: 22144434743     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548500500093225     Document Type: Review

References (50)

1. Avis, N. E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V, & Kagawa-Singer, M. (2001). Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Social Science & Medicine, 52, 345-356.
2. Bastian, L. A., McBride, C. M., Fish, L., Lyna, P., Farrell, D., Lipkus, I. M., Rimer, B. K., & Sieger, I. C., (2002). Evaluating participants' use of a hormone replacement decision-making intervention. Patient Education and Counseling, 48, 283-291.
3. Bunton, R., Burrows, R., & Nettleton, S., (1995). The sociology of health promotion. Critical analyses of consumption, lifestyle and risk. London: Routledge.
4. Campioni, M. (1997). Revolting Women: Women in Revolt. In P. A. Komesaroff, P. Rothfield, and J. Daly, (Eds.) Reinterpreting Menopause: Cultural and Philosophical Issues. New York: Routledge.
5. Clark, H. D., O'Connor, A. M., Graham, I. D., & Wells, G. A. (2003). What factors are associated with a woman's decision to take hormone replacement therapy? Evaluated in the context of a decision aid. Health Expectations. 6, 110-117.
6. Commonwealth of Australia. (2000) Improving health care through consumer participation: A resource guide for organisations. Canberra: Commonwealth Department of Health and Aged Care.
7. Coney, S. (1992a). The exploitation of fear: Hormone replacement therapy and the menopausal woman. In P. Davis, (Ed.) For Health or Profit? Auckland: Oxford University Press.
8. Coney, S. (1992b). The exploitation of fear - the selling of HRT. Healthsharing Women Research Issues Forum II. Papers and Procedings. April 1992. Melbourne.
9. Coney, S. (1993). The Menopause Industry. Melbourne: Spinifex.
10. Davis, M. E., Lanzl, L. H., & Strandjord, N. M. (1966). Estrogens and the aging process. The detection, prevention, and retardation of osteoporosis. Journal of the American Medical Association, 196, 219-24.
11. Department of Health, UK. (2001). The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. 14 September 2001.
12. Department of Health, UK. (2004) Choosing Health: making healthier choices easier. 16 November 2004.
13. Flint, M., Kronenberg, F., & Utian, W. (1990). Annals of the New York Academy of Sciences: Multidisciplinary Perspectives on Menopause. 592, 114-22.
14. Greer, G. (1991). The Change: Women, Ageing and the Menopause. London: Hamish Hamilton.
15. Harding, J. (1997). Bodies at risk: Sex, surveillance and hormone replacement therapy. Petersen, A., and Bunton, R., (Eds.) Foucault, Health and Medicine. London: Routledge.
16. Harding, S. (1991). Whose Science? Whose Knowledge? Thinking from Women's Lives. Milton Keynes: Open University Press.
17. Hunter, M. S., & O'Dea, I. (1997). Menopause: Bodily Changes and Multiple Meanings. In J. Ussher. (Ed) Body Talk: The Material and Discursive Regulation of Sexuality, Madness and Reproduction. London: Routledge.
18. Kaufen, P. A. (1990). Methodological Issues in Menopause Research. Annals of the New York Academy of Sciences: Multidisciplinary Perspectives on Menopause, 592, 114-22.
19. Klein, R. (1992). The unethics of hormone replacement therapy. Bioethics News, 11, 24-37.
20. Klein, R., & Durable, L. J. (1994). Disempowering Midlife Women: The Science and Politics of Hormone Replacement Therapy (HRT). Women's Studies International Forum, 17, 327-343.
21. Komesaroff, P., Rothfield, P., & Daly. J. Reinterpreting Menopause: Cultural and Philosophical Issues. New York: Routledge.
22. Kuhn, T. S. (1970). The Structure of Scientific Revolutions. 2nd edn. Chicago: University Chicago Press.
23. Latour, B., & Woolgar, S. (1986). Laboratory Life: the Construction of Scientific Facts. 2nd edn. Princeton, NJ: Princeton University Press.
24. Leng, K. W. (1997). Menopause and the great divide: Biomedicine, feminism and cyborg politics. In Komesaroff, P., Rothfield, P. and Daly, J., (Eds.) Reinterpreting Menopause: Cultural and Philosophical issues. New York: Routledge.
25. Lyons, A., & Griffin, C. (2000) Representations of Menopause and Women at Midlife. In J. Ussher. Women's health: contemporary international perspectives. Leicester: British Psychological Society.
26. MacLennan, A. (1991). Consensus statement. Hormone replacement therapy and the menopause. Medical Journal of Australia, 155, 43-44.
27. MacLennan, A., MacLennan, A., & Wilson, D. (1993). The prevalence of oestrogen replacement therapy in South Australia. Maturitas, 16, 175-183.
28. MacLennan, A. H., & Smith, M. (1995). Hormone Replacement Therapy and Breast Cancer: what are the facts? Medical Journal of Australia, 163, 483-85.
29. Martin, E. (1997). The woman in the menopausal body. Komesaroff, P., P. Rothfield, and J. Daly, (Eds) Reinterpreting Menopause: cultural and philosophical issues. London: Routledge.
30. McCrea, F. B. (1983). The politics of menopause: The discovery of a deficiency disease. Social Problems, 31, 111-123.
31. Murtagh, M. J. (2002). Intersections of medical and feminist discourses of menopause: risk, choice and agency. PhD thesis. University of Adelaide.
32. Murtagh, M. J., & Hepworth, J. (2003a). Menopause as a long-term risk to health: Implications of general practitioner accounts of prevention for women's choice and decision-making. Sociology of Health and Illness, 25, 185-207.
33. Murtagh, M. J., & Hepworth, J. (2003b). Feminist Ethics and Menopause: autonomy and decision making by women in primary medical care. Social Science and Medicine, 56, 1643-1652
34. Murtagh, M. J., & Rapley, T. (2003). The very idea of shared decision making. Shared Decision Making Conference. 2-4 September 2003. Swansea, UK.
35. Petersen, A., & Lupton, D. (1996). The New Public Health: Health and Self in the Age of Risk. St. Leonards, NSW: Allen and Unwin.
36. Petitti, D. B. (1995). Hormone Replacement Therapy: Risks and Benefits. Female Patient, 5, 23-27.
37. Rose, G. (1992). The Strategy of Preventive Medicine. Oxford: Oxford University Press.
38. Say, R. E, Thomson, R., & Murtagh, M. J. (In Press) Review of factors involved in patients' decision-making preference. Patient Education and Counseling.
39. Speroff, L. (2000) It's time to stop using the word 'replacement'. Maturitas, 34, 1-3.
40. Theroux, R., & Taylor, K. (2003) Women's decision making about the use of hormonal and non hormonal remedies for the menopause transition. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN/ NAACOG , 2003 Nov-Dec, 32(6): 712-23.
41. Thomson, R. G., Bowling, A., & Moss, F. (2001). Engaging patients in decisions: a challenge to health care delivery and public health. Quality in health care, 10, Suppl 1:i1.
42. Utian, W.H. (1990). The menopause in perspective: From potions to patches. Annals of the New York Academy of Sciences: Multidisciplinary Perspectives on Menopause, 592, 1-7.
43. Utian, W. H. (1997). Pieter van Keep Memorial Lecture. Menopause-a modern perspective from a controversial history. Maturitas, 26, 73-82.
44. Walter, F. M. Emery, J. D., Rogers, M., & Britten, N. (2004). Women's views of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy. Patient Education and Counseling, 53, 121-128.
45. Wanless, D. Securing our future health: taking a long-term view (final report) London. HM Treasury.
46. Wass, A. (1994). Promoting Health: The Primary Health Care Approach. Sydney: Harcourt Brace and Company.
47. Welton, A., Hepworth, J., Collins, N. et al. (2004). Decision-making about hormone replacement therapy by women in England and Scotland. Climacteric, 7, 41-49.
48. Wilson, R. (1966). Feminine Forever. London: Allen.
49. Wilson, R., & Wilson, T. (1963). The fate of the nontreated postmenopausal woman: a plea for the maintenance of adequate oestrogen from puberty to the grave. Journal of the American Geriatric Society, 11, 1-12.
50. Worcester, N. and Whatley, M. H. (1992). The selling of HRT: playing the fear factor. Feminist Review, 41, 1-26.